Statements (27)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:chemical_compound
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:AMX-0035
|
gptkbp:activities |
increases phenylalanine levels
|
gptkbp:appointed_by |
oral medication
oral route |
gptkbp:approves |
gptkb:FDA
|
gptkbp:brand |
Buphenyl
|
gptkbp:developed_by |
butyric acid
|
gptkbp:discovered_by |
the 1970s
|
gptkbp:dissolved |
soluble in water
|
https://www.w3.org/2000/01/rdf-schema#label |
sodium phenylbutyrate
|
gptkbp:ingredients |
C10 H11 Na O2
|
gptkbp:is_available_on |
tablets
powder |
gptkbp:is_considered |
a nitrogen scavenger
|
gptkbp:is_part_of |
treatment regimen for urea cycle disorders
|
gptkbp:is_used_by |
patients with metabolic disorders
|
gptkbp:is_used_for |
treatment of urea cycle disorders
|
gptkbp:mass |
182.23 g/mol
|
gptkbp:related_to |
phenylbutyric acid
|
gptkbp:side_effect |
nausea
abdominal pain diarrhea |
gptkbp:social_structure |
aromatic compound
|
gptkbp:type_of |
507-55-1
|
gptkbp:used_in |
clinical trials
|